Trial Using TEG® 5000 Hemostasis Analyzer System Featured in Circulation Journal

[back to news]

Scientific journal Circulation recently highlighted the results of the CREATIVE trial, in which physicians used our TEG® 5000 Hemostasis Analyzer System to help identify patients who may be at high risk for complications after undergoing percutaneous coronary intervention (PCI), also known as stenting.

The Clopidogrel Response Evaluation and AnTi-platelet InterVEntion in High Thrombotic Risk PCI Patients (CREATIVE) study was conducted at one of the largest cardiology hospitals in China, Fuwai Cardiovascular Hospital in Beijing, and Yi-Da Tang, M.D., Ph.D., was the lead investigator.

Read more about the study.

TEG system